In a clinical setting, TNF-α inhibitors are widely used to treat TNF-α-associated disorders, including rheumatoid arthritis, psoriasis, ankylosing spondylitis, Crohn’s disease, diabetes mellitus, Alzheimer’s disease, and cancer [22]. This evidence concerns the gene TNF and rheumatoid arthritis.